Elanco Animal Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Outlook Therapeutics (OTLK) halted, news pending
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
Elanco Animal Health (ELAN) Tops Q3 EPS by 4c, Trims FY Guidance
November 6, 2019 6:46 AM ESTElanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.30, $0.04 better than the analyst estimate of $0.26. Revenue for the quarter came in at $771.3 million versus the consensus estimate of $765.43 million.
GUIDANCE:
Elanco Animal Health sees FY2019 EPS of $1.04-$1.08, versus the... More
